| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 67925 | Null | 0.0438391811600409 | 0.063643419 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.0438391811600409 | 0.27333172 |
| NSC 700122 | Null | 0.0438391811600409 | 0.10286503 |
| NSC 706739 | Benzo[c]pyrrolo[3,4-a]carbazole-1,3(2H,3aH)-dione, 2-(dimethylamino)-5-ethyl- 3b,4,5,6,7,7a,12,12b-octahydro-9-methyl- | 0.0438391811600409 | 0.20881907 |
| NSC 723654 | 1-(3-Oxo-hex-1-enylsulfanyl)-hex-1-en-3-one | 0.0438391811600409 | -0.011377551 |
| NSC 736739 | E2GG, 5,7-bis[(4-methoxybenzyl)amino]-3-isopropylpyrazolo[4,3-d]py rimidine | 0.0438391811600409 | 0.13237166 |
| NSC 756173 | GSK326090A | 0.0438391811600409 | 0.10014955 |
| NSC 757925 | 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide | 0.0438391811600409 | 0.16354138 |
| NSC 763564 | EMD-534085 | 0.0438391811600409 | 0.13130698 |
| NSC 85235 | 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) | 0.0438391811600409 | -0.017047212 |